Influenza immunisation: knowledge and actions taken by <scp>UK HIV</scp>‐positive adults

Ellis, Joanna; Brown, James; Smith, Colette; Snell, Luke B; Capocci, Santino; Ferro, Filippo Maria; Ferreira, Jeruti; Marshall, Neal; Webster, Daniel P.; Johnson, Margaret; Lipman, Marc

doi:10.1111/hiv.12309

Cited by 3 publications

(2 citation statements)

References 17 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,2 Annual influenza immunisation is recommended for all HIV-positive adults in the UK, supported by British HIV Association (BHIVA) guidelines, 1 with evidence for reasonably good uptake. 3 HIV services do not receive specific funding to provide immunisation; and the National Flu Immunisation Programme offers this instead via primary care and pharmacies. 4 Whether this meets the needs of people living with HIV has not been evaluated.…”

Section: Access To Influenza Immunisation Services By Hiv-positive Pamentioning

confidence: 99%

Access to influenza immunisation services by HIV‐positive patients in the UK

Pickett

Brown

Schalkwyk

et al. 2018

Influenza Resp Viruses

View full text Add to dashboard Cite

Section: Access To Influenza Immunisation Services By Hiv-positive Pamentioning

confidence: 99%

Access to influenza immunisation services by HIV‐positive patients in the UK

Pickett

Brown

Schalkwyk

et al. 2018

Influenza Resp Viruses

View full text Add to dashboard Cite

“…Both of which are recommended for PLWH, (53,54) with evidence of reasonable uptake in the UK. (55) It is important, however, to ensure that the provision of these immunisations meets the needs of the HIV positive population and so maximises their impact. (56) Although the risk of TB is significantly reduced by the provision of ART, (2) PLWH remain at greater risk of TB than the general population, in particular those who have migrated from high TB incidence settings.…”

Section: Crossmentioning

confidence: 99%

HIV and respiratory illness in the antiretroviral therapy era

Jaffer¹,

Devani²,

Brown³

et al. 2017

Ann. Res. Hosp.

View full text Add to dashboard Cite

Respiratory illness is a common manifestation of HIV infection. The availability of effective antiretroviral therapy (ART) has changed the pattern of respiratory ill-health experienced by people living with HIV (PLWH). Among populations with good access to ART, opportunistic respiratory infections such as Pneumocystis jirovecii pneumonia (PCP) are becoming less frequent. However, there is evidence to suggest that these populations may be at greater risk of serious non-AIDS illness including chronic respiratory disease. Although there is remaining uncertainty about the extent to which HIV represents an independent risk-factor for respiratory illness in individuals with a suppressed HIV viral load and immune reconstitution, in many settings PLWH have greater exposure to risk factors for respiratory illness (in particular tobacco smoking), which contribute to this burden of disease. As HIV-positive populations age, management of these conditions will therefore become increasingly important. Healthcare services need to manage this growing burden of chronic respiratory illness and provide access to preventative measures including smoking cessation and immunisation against vaccine-preventable respiratory infections in a way that is appropriate to the populations served.

show abstract